History | Ixekizumab for treating moderate to severe plaque psoriasis | Guidance | NICE

History

Documents created during the development process.

Expected publication

Equality Impact Assessment (Guidance development) (PDF 236 KB)

Published:

26 April 2017

Final appraisal determination

Final appraisal determination
Final appraisal determination document (PDF 444 KB)

Published:

10 March 2017
Committee papers (PDF 1.65 MB)

Published:

10 March 2017
Public committee slides (PDF 433 KB)

Published:

10 March 2017

Draft guidance

Draft guidance
Appraisal consultation document (PDF 158 KB)

Published:

01 November 2016
Committee papers (PDF 20.67 MB)

Published:

01 November 2016
Committee papers (PDF 469 KB)

Published:

01 November 2016

Draft scope documents

Draft scope (pre-referral) (PDF 138 KB)

Published:

20 May 2016
Provisional matrix (pre-referral) (PDF 38 KB)

Published:

20 May 2016

Invitation to participate

Final scope (PDF 87 KB)

Published:

22 June 2016
Final matrix (PDF 90 KB)

Published:

22 June 2016
NICE's response to comments on the draft scope and provisional matrix (PDF 118 KB)

Published:

22 June 2016
Equality impact assessment (Scoping) (PDF 63 KB)

Published:

22 June 2016